Since its origins in 1960, Janvier Group has evolved into an essential partner in Drug Discovery & Preclinical Research, providing more than 3500 clients worldwide with a unique combination of models and innovative solutions. We leverage the latest technologies to deliver well-characterized in vitro, in vivo, and custom-created models, as well as a range of tailored services to support your research from hit identification to candidate selection, with strong expertise in understanding mechanisms of action. Janvier Group operates internationally with a team of over 600 dedicated experts.

Discover our new website in 2025.
Talk to our specialized teams today: